[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356092-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356092-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","malat1-gene-variants-rs619586-rs664589-and-rs3200401-their-association-with-non-hodgkin-lymphoma-risk-evidence-from-a-case-control-study-in-southeast-iran","MALAT1 Gene Variants rs619586, rs664589, and rs3200401 - Their Association with Non-Hodgkin Lymphoma Risk: Evidence from a Case-Control Study in Southeast Iran","","Non-Hodgkin lymphoma (NHL) is a heterogeneous hematologic malignancy in which genetic and epigenetic factors contribute to disease susceptibility. This case-control study evaluates three MALAT1 single nucleotide polymorphisms (rs619586 A>G, rs664589 C>G, rs3200401 C>T) in a Zahedan, Iran population sample. Using PCR-RFLP and ARMS-PCR genotyping and chi-square, t-tests, and logistic regression, the analysis shows rs3200401 C>T and rs619586 A>G associate with reduced NHL risk, while rs664589 C>G shows no significant effect. Results suggest MALAT1 variants and a TCG haplotype may act as genetic biomarkers, warranting larger multi-ethnic validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/malat1-gene-variants-rs619586-rs664589-and-rs3200401-their-association-with-non-hodgkin-lymphoma-risk-evidence-from-a-case-control-study-in-southeast-iran/356092/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/malat1-gene-variants-rs619586-rs664589-and-rs3200401-their-association-with-non-hodgkin-lymphoma-risk-evidence-from-a-case-control-study-in-southeast-iran/356092.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of this study on MALAT1 and non-Hodgkin lymphoma?","Question",{"text":63,"@type":64},"To assess whether three MALAT1 SNPs (rs619586, rs664589, rs3200401) are associated with susceptibility to non-Hodgkin lymphoma in a Zahedan, Iran sample.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the MALAT1 polymorphisms genotyped?",{"text":68,"@type":64},"Genotyping used PCR-RFLP and amplification refractory mutation system PCR (ARMS-PCR) on genomic DNA isolated from peripheral blood leukocytes.",{"name":70,"@type":61,"acceptedAnswer":71},"Which MALAT1 variants were linked to NHL risk and which were not?",{"text":72,"@type":64},"rs3200401 C>T and rs619586 A>G were significantly associated with reduced NHL risk, while rs664589 C>G showed no significant differences in genotype or allele frequencies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356092,1790190843,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:07/14/2025 Acceptance:01/28/2026 Published:02/06/2026 |\n| --- | --- |\n\nMALAT1 Gene Variants rs619586, rs664589, and rs3200401 and Their Association with Non-Hodgkin Lymphoma Risk: Evidence from a Case-Control Study in Southeast Iran  \nHosien Mozaffari1, Seyed Mehdi Hashemi2, Masoomeh Sadraei1, Mohsen Taheri3, Mehrdad Behdani1, Gholamreza Bahari1,4 *  \nAbstract  \nIntroduction: Non-Hodgkin lymphoma (NHL) represents a diverse spectrum of lymphoid malignancies, which are defined by abnormal proliferation of lymphocytes and the absence of Reed–Sternberg cells. Both genetic and epigenetic mechanisms play critical roles in the etiology of this group of cancers. In this context, the present study aimed to assess the potential relationship between three specific single nucleotide polymorphisms (SNPs) in the MALAT1 gene namely rs619586 A>G, rs664589 C>G, and rs3200401 C>T and their association with susceptibility to NHL in a population sample from Zahedan, Iran. Materials and Methods: A case-control study design was utilized, comprising 185 individuals diagnosed with NHL (118 men and 67 women; mean age: 45.46 ± 15.44 years) and an equal number of age-and sex-matched healthy controls (106 men and 79 women; mean age: 43.26 ± 12.27 years) . Genomic DNA was isolated from peripheral blood leukocytes using the conventional salting-out method. Genotyping for the selected MALAT1 polymorphisms was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and amplification refractory mutation system PCR (ARMS-PCR) methodologies. Statistical evaluations were performed using chi-square tests, independent sample t-tests, and logistic regression models to analyze the data. Results: The rs3200401 C>T polymorphism of the MALAT1 gene was significantly associated with a reduced risk of NHL, suggesting a protective effect (P\u003C0.05) . Similarly, the rs619586 A>G variant showed a significant protective association with NHL. In contrast, the rs664589 C>G polymorphism did not show any significant differences in genotype or allele frequencies between NHL patients and healthy subjects (P>0.05) . Conclusion: The findings suggest that MALAT1 gene polymorphisms, particularly rs3200401 andrs619586, as well as the TCG haplotype, may influence susceptibility to non-Hodgkin lymphoma and serve as potential genetic biomarkers. However, further studies involving larger and ethnically diverse cohorts are required to validate these associations.  \nKeywords: Non-Hodgkin lymphoma, MALAT1, polymorphism, gene association, lncRNA  \nAsian Pac J Cancer Prev, 27 (2), 629-635  \nIntroduction  \nNon-Hodgkin lymphoma (NHL) is a type of hematological cancer that affects people of all ages and contributes significantly to cancer mortality. The need for early diagnosis, combined with the use of complex and expensive treatments, places a significant financial burden on patients, their families, and the healthcare system [1] . Lymphoma is a type of lymphatic cancer that originates in lymphocytes and spreads to lymph nodes, the spleen, the thymus, and the bone marrow. This disease causes uncontrolled cell growth and tumor formation in the lymphatic system due to genetic and biochemical  \nchanges [2] .  \nA meta-analysis study in Iran showed that the prevalence of leukemia and lymphoma is 3.26% and 7.15%, respectively, which is influenced by demographic, environmental, and genetic factors [3] .  \nLymphomas are generally divided into Hodgkin lymphoma (HL), representing around 10% of cases, and NHL, which represents about 90% . The primary distinction between the two types is the presence of Reed-Sternberg cells in Hodgkin lymphoma, which are found in tissue samples with specific histopathological characteristics, whereas these cells are absent in non-Hodgkin lymphoma [4]. The global incidence of NHL  \n1Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan,","cbCaitMVAtJZXKiI","https://ap.wps.com/l/cbCaitMVAtJZXKiI","pdf",638328,"English","# Abstract\n# Introduction\n## Non-Hodgkin lymphoma background\n## Long non-coding RNAs and MALAT1\n# Materials and Methods\n# Results\n# Conclusion","[{\"question\":\"What was the purpose of this study on MALAT1 and non-Hodgkin lymphoma?\",\"answer\":\"To assess whether three MALAT1 SNPs (rs619586, rs664589, rs3200401) are associated with susceptibility to non-Hodgkin lymphoma in a Zahedan, Iran sample.\"},{\"question\":\"How were the MALAT1 polymorphisms genotyped?\",\"answer\":\"Genotyping used PCR-RFLP and amplification refractory mutation system PCR (ARMS-PCR) on genomic DNA isolated from peripheral blood leukocytes.\"},{\"question\":\"Which MALAT1 variants were linked to NHL risk and which were not?\",\"answer\":\"rs3200401 C\\u003eT and rs619586 A\\u003eG were significantly associated with reduced NHL risk, while rs664589 C\\u003eG showed no significant differences in genotype or allele frequencies.\"}]","MALAT1 Gene Variants rs619586, rs664589, and rs3200401 - Their Association with Non-Hodgkin Lymphoma Risk: Evidence from a Case-Control Study in Southeast Iran | PDF",1790123364,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acd1d6b3c7f4ef9cf8e5e8f1f69ba563.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45d7c0e34052801621e3b5a1a45e8d8b.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/914df626e24ccf916455a0031381fe2e.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23535ea5104b205f6832aa47900e4378.webp",980,1385]